303 related articles for article (PubMed ID: 10871853)
1. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b.
Schnelzer A; Prechtel D; Knaus U; Dehne K; Gerhard M; Graeff H; Harbeck N; Schmitt M; Lengyel E
Oncogene; 2000 Jun; 19(26):3013-20. PubMed ID: 10871853
[TBL] [Abstract][Full Text] [Related]
2. Purification and biochemical properties of Rac1, 2, 3 and the splice variant Rac1b.
Haeusler LC; Hemsath L; Fiegen D; Blumenstein L; Herbrand U; Stege P; Dvorsky R; Ahmadian MR
Methods Enzymol; 2006; 406():1-11. PubMed ID: 16472645
[TBL] [Abstract][Full Text] [Related]
3. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors.
Jordan P; Brazåo R; Boavida MG; Gespach C; Chastre E
Oncogene; 1999 Nov; 18(48):6835-9. PubMed ID: 10597294
[TBL] [Abstract][Full Text] [Related]
4. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation.
Singh A; Karnoub AE; Palmby TR; Lengyel E; Sondek J; Der CJ
Oncogene; 2004 Dec; 23(58):9369-80. PubMed ID: 15516977
[TBL] [Abstract][Full Text] [Related]
5. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
[TBL] [Abstract][Full Text] [Related]
6. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
7. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of Rac1 pseudogenes (psi1Rac1-psi4Rac1) in the human genome.
Kugler MC; Gerhard M; Schnelzer A; Borzym K; Reinhardt R; Schmitt M; Lengyel E
Gene; 2004 Oct; 341():189-97. PubMed ID: 15474301
[TBL] [Abstract][Full Text] [Related]
10. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase.
Zuo Y; Shields SK; Chakraborty C
Biochem Biophys Res Commun; 2006 Dec; 351(2):361-7. PubMed ID: 17064663
[TBL] [Abstract][Full Text] [Related]
11. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T
Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585
[TBL] [Abstract][Full Text] [Related]
12. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines.
Jeffery PL; Murray RE; Yeh AH; McNamara JF; Duncan RP; Francis GD; Herington AC; Chopin LK
Endocr Relat Cancer; 2005 Dec; 12(4):839-50. PubMed ID: 16322325
[TBL] [Abstract][Full Text] [Related]
16. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23.
Tseng YH; Vicent D; Zhu J; Niu Y; Adeyinka A; Moyers JS; Watson PH; Kahn CR
Cancer Res; 2001 Mar; 61(5):2071-9. PubMed ID: 11280768
[TBL] [Abstract][Full Text] [Related]
17. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
Zhang B; Zhang Y; Dagher MC; Shacter E
Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605
[TBL] [Abstract][Full Text] [Related]
18. Suppression of nuclear Wnt signaling leads to stabilization of Rac1 isoforms.
Esufali S; Charames GS; Bapat B
FEBS Lett; 2007 Oct; 581(25):4850-6. PubMed ID: 17888911
[TBL] [Abstract][Full Text] [Related]
19. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
20. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
Luo RZ; Fang X; Marquez R; Liu SY; Mills GB; Liao WS; Yu Y; Bast RC
Oncogene; 2003 May; 22(19):2897-909. PubMed ID: 12771940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
